Skip to main content
logo
Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.400
+0.070 (5.26%)
Aug 6, 2026, 4:00 PM EDT - Market closed

Allarity Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.350.32----
Revenue Growth
------
Gross Profit
0.350.32----
Operating Income
-12.26-12.61-27.24-17.13-34.46-26.56
Net Income
-8.5-11.23-25.15-20.42-21.05-26.65
Earnings Per Share
-0.72-0.78-15.65---
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
19.8114.6919.530.172.0319.91
Total Debt
21.51.41.351.33.741.09
Net Cash (Debt)
-1.6813.2918.18-1.13-1.7118.82
Net Cash Growth
--26.93%----
Net Cash Per Share
-0.110.9211.31---

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-16.63-14.82-17.35-12.75-16.82-14.89
Capital Expenditures
--0.01-0.3--0.02-
Free Cash Flow
-16.63-14.83-17.65-12.75-16.84-14.89
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%----
Operating Margin
-3552.75%-3939.06%----
Pretax Margin
-2463.48%-3509.69%----
Profit Margin
-3260.58%-3509.69%----
FCF Margin
-4819.42%-4633.75%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
64.5754.27----